Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19 [Corrigendum]
Year: 2025
Type: erratum
Abstract: [This corrects the article DOI: 10.2147/IJN.S313093.].
DOI: 10.2147/ijn.s587907
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,836
OpenAlex ID: W4417232977
Cites:
Cited by:
Related to: